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Nowadays, head and neck squamous cell carcinoma (HNSCC) treatment failure is 
mostly explained by locoregional progression or intrinsic radioresistance. Radiotherapy 
(RT) has recently evolved with the emergence of heavy ion radiations or new fractionation 
schemes of photon therapy, which modify the dose rate of treatment delivery. The aim 
of the present study was then to evaluate the in vitro influence of a dose rate variation 
during conventional RT or carbon ion hadrontherapy treatment in order to improve the 
therapeutic care of patient. In this regard, two HNSCC cell lines were irradiated with 
photons or 72  MeV/n carbon ions at a dose rate of 0.5, 2, or 10  Gy/min. For both 
radiosensitive and radioresistant cells, the change in dose rate significantly affected cell 
survival in response to photon exposure. This variation of radiosensitivity was associated 
with the number of initial and residual DNA double-strand breaks (DSBs). By contrast, 
the dose rate change did not affect neither cell survival nor the residual DNA DSBs 
after carbon ion irradiation. As a result, the relative biological efficiency at 10% survival 
increased when the dose rate decreased. In conclusion, in the RT treatment of HNSCC, 
it is advised to remain very careful when modifying the classical schemes toward altered 
fractionation. At the opposite, as the dose rate does not seem to have any effects after 
carbon ion exposure, there is less need to adapt hadrontherapy treatment planning 
during active system irradiation.
Keywords: high- and low-leT irradiations, carbon ions, photons, dose rate, Dna double-strand breaks, head and 
neck squamous cell carcinoma
inTrODUcTiOn
Head and neck cancer is the sixth most common type of cancer worldwide. More than 600,000 
new patients are diagnosed per year among which approximately 350,000 will die (1). Over 60% 
of patients present a locally advanced stage (III–IV) at diagnosis, and despite improvements in the 
therapeutic management of this type of cancer in recent years, disease-free survival at 3 years does 
not exceed 30% and overall survival at 5 years is less than 50% (2). Three major therapeutic strategies 
are used for non-operated stage III and IV squamous cell carcinoma: (1) combined radiotherapy 
(RT) and concomitant platin-based chemotherapy (CT), (2) concomitant association of RT with 
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cetuximab (anti-EGFR), and (3) induction CT with a combina-
tion of docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by 
RT alone (3). If high response rates are observed after TPF ± RT 
(68 and 72%, respectively), with 8.5 and 17% of complete response 
(3, 4), disease-free survival remains poor. Recurrences are mainly 
related to a locoregional progression (85 and 86%), and this fail-
ure could be linked to an acquired or inherent radioresistance to 
low-LET radiation.
Improvements in RT over the last decade are linked to the 
emergence of intensity-modulated techniques and new protocols 
of altered fractionation, which modify the dose rate of treatment 
delivery or to the use of heavy ion species (5). Hyperfractionation 
shows improvements in survival of head and neck squamous cell 
carcinoma (HNSCC) patients (6) and hypofractionated schemes 
are efficient for palliation (7). However, limited biological data have 
up to now been published on the effect of a dose rate variation on 
the tumor survival. In parallel, hadrontherapy offers advantages 
over conventional RT due to the physical and biological properties 
of carbon ion irradiation, which have an enhanced radiobiological 
effectiveness (RBE) caused by the dense ionization, resulting in 
complex irreparable DNA lesions (8). Therefore, hadrontherapy 
is a very promising approach for treating radioresistant tumors 
located near organs at risk (9). However, carbon ions delivered 
by an active scanning system cause an important variation in 
the dose rate within the tumor volume. The deepest parts of the 
tumor are irradiated in less than 1 s, whereas the shallowest parts 
of the tumor are irradiated in a few minutes. Moreover, modern 
techniques of photon radiation, such as intensity-modulated RT, 
may increase the number of radiation fields, and thus the dose is 
delivered to the tumor in a longer time. If cellular radiosensitivity 
is dose rate dependent after photon exposure, very little is known 
about high-LET radiation dose rate response.
The aim of this work was then to better understand the effects 
of doses’ variations for high- and low-LET radiations on cancer 
cell lines in terms of radiosensitivity, cell survival, and DNA 
double-strand-breaks in order to better adapt the radio- and 
hadrontherapy treatment.
MaTerials anD MeThODs
cell culture
Two HNSCC cell lines were used. The radiosensitive SCC61 and 
the radioresistant SQ20B cell lines were grown, as previously 
described (10, 11).
irradiation Procedure
Photon irradiations were performed on a 250-kV irradiator 
(X-RAD 320, PXI), at the Lyon-Sud University (11) (UMS3444/
US8 platform, France), and carbon ion irradiations (72 MeV/n, 
LET 33.6 keV/μm), at Grand Accélérateur National d’Ions Lourds 
(GANIL, Caen, France), facilities, as previously described (12, 13).
analysis of clonogenic cell survival
Cell survival following irradiation was quantified using a colony 
forming assay, as previously described (12, 14). Ten to sixteen 
hours before irradiation, SCC61 and SQ20B cells were seeded 
in 25 cm2 flasks at different densities, depending on the dose of 
radiation. Cells were irradiated at room temperature at 1, 2, 3, 4, or 
5 Gy delivered at a dose rate of 0.5, 2, or 10 Gy/min, respectively. 
For each dose and dose rate tested, six flasks were irradiated at 
two different cell densities. After irradiation, flasks were replaced 
in the incubator at 37°C. After six cellular divisions, colonies 
were fixed with ethanol 95% and stained with Giemsa (1/20). The 
number of colonies containing at least 64 cells was counted using 
Coltcount (Optronix), and the surviving fractions were calculated 
using the formula S(D) = n(D)/PE × N(D), where n represents the 
number of colonies, N the seeded cell number, and PE the plating 
efficiency. Each experiment was realized in triplicate.
immunocytochemistry – γh2aX assay
The method was adapted from Tanaka et al. (15). Cells were irra-
diated at 1 and 2 Gy with photons or carbon ions at a dose rate of 
0.5, 2, or 10 Gy/min. At 15 min (only for photons), 30 min, 1, 2, 
and 24 h after irradiation, cells were trypsinized, washed with PBS, 
and fixed in 70% ice-cold ethanol for at least 24 h. Cells were then 
resuspended in PBS for a wash and incubated in permeabiliza-
tion buffer (20 mM HEPES, 50 mM NaCl, 3 mM MgCl2, 300 mM 
sucrose, and 0.5% Triton X-100 in PBS). After two washes in 
PBSMB (PBS 1% milk, 0.1% BSA), cells were incubated for 2 h 
with gentle agitation in a primary antibody solution consisting of 
an antiphospho-histone-H2AX (serine139) mouse monoclonal 
IgG1 antibody (Millipore, Watford, UK) diluted at 1/2000 in 
PBSMB. Excess primary antibody was removed by washing twice 
in PBSMB buffer. A secondary antibody solution consisting of 
Alexa Fluor-488 goat-antimouse IgG antibody (Invitrogen) 
diluted at 1/1000 in blocking buffer was added to each sample 
and incubated for 20 min at room temperature. Excess second-
ary antibody was removed by washing twice with PBSMB. Cells 
were finally resuspended in PBS for flow cytometry analysis. A 
minimum of 10,000 cells were analyzed using a FACS-BD-LSRII.
statistical analysis
Statistical analyses were performed using the R software. The 
two-way ANOVA statistical test was used to compare the interac-
tion between the dose and the dose rate in order to determine the 
significance of the differences (a p-value <0.05 was considered 
statistically significant). The Student’s t-test was also used to 
compare values between groups.
resUlTs
influence of Dose rate Variation on 
hnscc radiosensitivity after high- and 
low-leT exposure
Figure 1 shows the dose–response curves for cell killing induction 
in the radiosensitive SCC61 and radioresistant SQ20B cells after 
exposure to both carbon ion beams and photons. In response to 
photon irradiation, a significant change in the survival fraction 
at 2 Gy (SF2) and the dose for 10% survival (D10) was observed 
for both cell lines depending on the dose rate. For SCC61 cells, 
the SF2 obtained after a 0.5 Gy/min photon irradiation was 0.39, 
whereas it significantly fell to 0.24 after a 2 Gy/min and to 0.20 
after a 10 Gy/min irradiation. When statistical analysis was done, 
a significant difference (p =  0.02) between the three dose rate 
FigUre 1 | Dose–response curves for killing of scc61 (a,c) and sQ20B cells (B,D) in response to photon (a,B) or 72 MeV/n carbon ion (c,D) 
irradiation at a dose rate of 0.5 gy/min (full square), 2 gy/min (full triangle), or 10 gy/min (full diamonds). Values represent the mean ± SD of three 
independent experiments performed in sextuplicate.
TaBle 1 | radiobiological parameters of scc61 and sQ20B cell lines for a 0.5, 2, or 10 gy/min photon or carbon ion irradiation.
Dose rate (gy/min) sF2 photons sF2 carbon ions D10 photons D10 carbon ions rBe
SCC61 0.5 0.39 0.09 3.9 1.9 2.1
2 0.24 0.07 3.1 1.7 1.8
10 0.20 0.07 2.7 1.7 1.6
SQ20B 0.5 0.76 0.26 6.9 3.4 2.0
2 0.71 0.26 6.0 3.4 1.8
10 0.50 0.26 4.4 3.4 1.3
SF2, survival fraction at 2 Gy; D10, dose for 10% survival; RBE, relative biological effect of carbon ions at 10% survival.
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survival curves was observed. The same variation of the SF2 was 
observed for the radioresistant cell line SQ20B, where the SF2 
value changed from 0.76 after a 0.5 Gy/min photon irradiation 
to 0.71 after a 2 Gy/min irradiation and to 0.50 after a 10 Gy/min 
irradiation (Table 1). A significant difference (p = 0.04) between 
the different dose rate survival curves was also observed.
The survival curves realized after carbon ion irradiation were 
fitted either using simple linear or linear quadratic fit curves. 
Whatever the fit considered, and conversely to photon irradia-
tion, dose rate changes in response to carbon ion irradiation did 
not affect the radiosensitivity. Whatever the radiosensitivity of 
the cells, the variation of the dose rate did not cause any change 
in cell survival, SF2, or D10 values. For SQ20B cells, the SF2 is 
0.26 whatever the dose rate considered. For the SCC61 cell line, 
SF2 varies from 0.09 to 0.07 depending on the dose rate (p = 0.21 
for the three survival curves with linear fit and p = 0.14 for linear 
quadratic fit).
From these results, the RBE at 10% survival was calculated 
(Table 1). The RBE increased when the dose rate decreased both 
in the radiosensitive and radioresistant cell lines. For a dose rate 
of 0.5 Gy/min, RBE values are 2.1 and 2.0 for SCC61 and SQ20B 
cells, respectively; and they fall to 1.6 and 1.3 when a dose rate of 
10 Gy/min is applied.
Dna Double-strand-Break analysis by 
γh2aX Flow cytometry assay
Figures  2 and 3 show the γH2AX fluorescence for both cell 
lines after photon or carbon ion exposure reported to that of 
FigUre 3 | Kinetic study of γh2aX foci. SCC61 (a) and SQ20B cells (B) were irradiated with 1 Gy carbon ions at a dose rate of 0.5 Gy/min (full square),  
2 Gy/min (full triangle), or 10 Gy/min (full diamonds). A kinetic study at 10 Gy/min for 2 Gy carbon ions is represented in dotted line. Short time points are 
represented in the insert. The percentage of γH2AX foci was calculated using sham-irradiated cells. For each time point, 10,000 cells were analyzed by flow 
cytometry. Values represent the mean ± SD of two independent experiments performed in triplicate.
FigUre 2 | Kinetic study of γh2aX foci. SCC61 (a,c) and SQ20B cells (B,D) were irradiated with 1 or 2 Gy photons at a dose rate of 0.5 Gy/min  
(full square), 2 Gy/min (full triangle), or 10 Gy/min (full diamonds). Short time points are represented in the insert. The percentage of γH2AX foci was calculated using 
sham-irradiated cells. For each time point, 10,000 cells were analyzed by flow cytometry. Values represent the mean ± SD of one or two independent experiments 
performed in triplicate. *p < 0.05, **p < 0.01, and ***p < 0.001.
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sham-irradiated controls. Different kinetic studies, from 15 min 
to 24  h, were realized after 1 and 2  Gy photon or carbon ion 
exposure in order to compare the effect for the same physical dose 
(1 Gy photons compared to 1 Gy carbon ions and 2 Gy photons 
compared to 2 Gy carbon ions) as well as the effect for the same 
biological equivalent dose (1 Gy carbon ions compared to 2 Gy 
photons). The biological equivalent dose was calculated using an 
RBE of 2, previously calculated for a dose rate of 2 Gy/min (12).
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At equivalent biological dose of photons and carbon ions, 
the initial peak of γH2AX foci, obtained 30 min after irradia-
tion, was almost similar in both the radioresistant SQ20B and 
the radiosensitive SCC61 cells when the same dose rate was 
considered. At the opposite, for a same physical dose and a 
same dose rate, the initial peak for both cell lines was higher 
after a carbon ion irradiation compared with photon irradia-
tion. However, whatever the dose or the type of irradiation is, 
the intensity of the peak depended on the dose rate. As an 
example, for the SQ20B cells, 30 min after 1 Gy of carbon ions, 
the percentage of γH2AX fluorescence was 370 ± 39% compared 
to the sham-irradiated control for a dose rate of 0.5  Gy/min, 
521 ±  26% for 2 Gy/min, and 658 ±  52% for 10 Gy/min. For 
all types of radiations and cells, the decrease of the amount in 
γH2AX took longer time for the higher dose rate. If we consider 
the residual double-strand breaks (DSBs) 24 h after irradiation, 
the results differed between the types of irradiation for both cell 
lines. Indeed, an effect of the dose rate was obtained after photon 
irradiation, whereas none was found after carbon ion irradiation 
(1 or 2 Gy). For both SCC61 and SQ20B irradiated with 2 Gy 
photons, a higher percentage of residual γH2AX fluorescence 
was found at a dose rate of 10 Gy/min (190 ± 15 and 148 ± 16%, 
respectively) compared to 150 ± 11 and 98 ± 12%, respectively, 
when the dose rate decreases to 2  Gy/min. After a high-LET 
irradiation, the responses of both cell lines were different. For the 
radiosensitive cells, the residual number of DNA DSBs varied 
between 165 ±  23 and 123 ±  13% after 10 and 0.5  Gy/min, 
respectively, but this variation was not statistically significant. 
For the radioresistant cell line, the percentage of residual γH2AX 
foci was lower, between 132 ± 11 and 115 ± 3 for 10 and 0.5 Gy/
min, respectively, and also not significant.
DiscUssiOn
Our study demonstrates that a variation in the dose rate affects 
cell survival only for low-LET irradiation and that this variation 
does not depend on the initial radiosensitivity of the cell line 
considered. Although the effects of an important dose rate vari-
ation (gray per second to gray per hour) after low-LET radiation 
has been reported for several years (16), very few studies related 
these effects in regard to the intensity-modulated RT techniques 
or in response to high-LET irradiation. Therefore, the aim of 
our work was to study the effect of a dose rate variation during 
high- or low-LET irradiations in terms of cell survival and DNA 
DSB repair. Our study was realized using two HNSCC cell lines 
displaying opposite radiosensitivity, irradiated with photons or 
carbon ions at dose rates of 0.5, 2, or 10 Gy/min. These dose rates 
correspond to an irradiation time varying from 15 s to 20 min, 
matching with the irradiation duration associated with the active 
ion beam techniques, on one hand, and, to the sessions of multi-
field irradiation, on the other hand.
First of all, we confirmed previous data (16, 17) demonstrating 
that even with a very slight change in the dose rate of photon, a vari-
ation of radiosensitivity (SF2 and D10) was observed. Moreover, 
this variation does not depend on the intrinsic radiosensitivity. 
In response to photon irradiation, it has been previously reported 
that a significant reduction in the lethality, mutagenesis, and 
carcinogenesis was observed when the dose is delivered at low 
dose rates compared to high dose rates [for review, see Ref. (18)]. 
The advanced hypothesis to explain these results was that damage 
spreads more over a time at a low dose rate, which should allow 
cells to have more time to detect DNA damages and activate 
their repair systems (19). Our results obtained for both cell 
lines confirm this hypothesis and are in total accordance with 
our previous published study (20), which reported that more 
initial and residual γH2AX foci were found after photon irradia-
tion. Boucher et  al. (21) have also demonstrated that low-LET 
radiation-induced lethality at low dose rate was accompanied by 
a decreased number of DSBs. They have additionally highlighted 
the involvement of the non-homologous end joining pathway in 
the repair of gamma-induced DSBs at 20 mGy/min. The impact 
of the dose rate was also studied on the induction of apoptotic cell 
death. In lymphocyte, it appears that only a very low dose rate has 
an effect on the induction of apoptosis (22). This is of particular 
interest in head and neck locations, where intensity-modulated 
techniques are used, and dose rate variations are observed in the 
different planned beams. Since static intensity-modulated-RT 
is the gold standard for head and neck RT (23), this technique 
increases the treatment time compared to 3D conformational RT. 
Volumetric modulated arc therapy has thus been developed and 
reduced by 50% treatment time (24). This technique can limit 
intrafraction patients’ movements and maintain an acceptable 
dose rate through the decreased treatment time. In our study, 
dose rate influence in photon irradiation suggests that the 
radiation therapist has to take it into account when choosing the 
planning technique.
As no data, obtained in the same conditions, are up to now 
available with high-LET, the second important aim of this study 
was to evaluate the influence of a high-LET dose rate variation 
on HNSCC cells. We demonstrated that, in contrast to photon 
irradiation, a carbon ion dose rate variation did not significantly 
affect cell survival irrespective of whatever the intrinsic radio 
sensitivity of the cell line used. As a consequence, we have 
demonstrated that the RBE at 10% survival increased when the 
dose rate decreased. Our results are in accordance with Masunaga 
et al. (25) who have studied the RBE of 290 MeV/n carbon ions, 
a LET found in the healthy tissues, by changing only the photon 
dose rate in quiescent tumor cells. Unlike us, the LET used in this 
study correspond to that found at the beginning of the SOBP. In 
order to confirm our results, it would now be of great interest to 
test the influence of a dose rate variation with a higher LET cor-
responding to that found in the center of the tumor. Moreover, as 
experiments were done only in tumor cells, it would be essential 
to study the response of healthy tissue surrounding the tumor.
We also evaluated DNA damage in our work. Although there 
is a slight effect on initial DNA DSBs 30 min after carbon ion irra-
diation, depending on the dose rate, no difference was observed 
on the residual ones. It is now well established that a localized 
deposition of high-LET particle results in complex DNA DSBs 
that cause cell death, mutations, and genomic instability (20, 
26). By contrast, the repair mechanisms of high-LET-induced 
DSBs are not fully understood (27). From our results, we can 
assume that the DNA damage response processes seems to be 
different between photon and carbon ion irradiation and then 
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complementary experiments need to be done, in order to explain 
why there is no effect of the dose rate on cell survival after high-
LET irradiation.
In conclusion, this study was carried out to understand 
whether a variation of the dose rate during a photon altered 
fractionation, intensity-modulated-RT, or a hadrontherapy 
treatment could affect cell survival or not. This study was of 
crucial interest since during hadrontherapy there is an impor-
tant variation of the dose rate occurring within the tumor and 
since the adaptation of current HNSCC RT treatment schemes 
and techniques is still performed empirically. Thus, we have 
shown that in response to photon exposure, the change in dose 
rate significantly affected cell survival for both radiosensitive 
and radioresistant cells, this variation of radiosensitivity was 
directly correlated to the number of initial and residual DNA 
DSBs. By contrast, the dose rate change did not affect neither 
cell survival nor the residual DNA DSBs after carbon ion 
irradiation.
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